CHST11 and hepatocellular carcinoma: We divided HCC patients into Treg‐enriched and Treg‐decreased groups and found that in Treg‐enriched group, highly expressed CHST11 indicated adverse prognosis (HR = 1.91, 95% CI = 1.22–3, p = 0.0039; Figure 7F).